Erratum: Human papillomavirus-16 (HPV-16) infection association with CIAP-2 expression in head and neck cancer (Med Oncol (2012) 29 (2459-2465) DOI: 10.1007/s12032-011-0143-2);Human papillomavirus-16 (HPV-16) infection association with CIAP-2 expression in head and neck cancer

Medical Oncology

Volumn 29, Issue 4, 2012, Pages 2459-2465

  Mansour, Amal ^a   Ali, Marwa ^a   Helmy, Hussein ^a   Kassim, Samar ^a  

^a AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

Apoptosis; CIAP; Human papillomavirus; IAPs; PCR; RT PCR

Indexed keywords

CELLULAR INHIBITOR OF APOPTOSIS PROTEIN 2; INHIBITOR OF APOPTOSIS PROTEIN 2; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CLINICAL ARTICLE; DISEASE ASSOCIATION; FEMALE; GENE AMPLIFICATION; GENE LOCUS; HEAD AND NECK CANCER; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; MALE; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

EID: 84867983098     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-013-0766-6     Document Type: Erratum

References (32)

1. Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol. 2009;45(4):309-16.
2. World health statistics annual; 2010: 23-24. http://apps.who.int/ hpvcentre/statistics/dynamic/ico/country-pdf/EGY.pdf.
3. Misawa K, Imai A, Misawa Y, Iwasaki S, Mineta H. Isolated inverted papilloma of the sphenoid sinus associated with HPV type 16. The Int J Otorhinolaryngol. 2009;2(9):1528-8420.
4. Louvanto K, Syrjänen KJ, Rintala MA, Grénman SE, Syrjänen SM. Human papillomavirus and predictors of cervical intraepithelial neoplasia among young mothers in a prospective follow-up study. Acta Obstet Gynecol Scand. 2011;90(2):167-73.
5. Worden FP, Kumar B, Lee JS, Wolf GT, Cordell KG, Taylor JM, Urba SG, Eisbruch A, Teknos TN, Chepeha DB, Prince ME, Tsien CI, D'Silva NJ, Yang K, Kurnit DM, Mason HL, Miller TH, Wallace NE, Bradford CR, Carey TE. Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: response and survival positively associated with HPV16 copy number. J Clin Oncol. 2008;26:3138-46.
6. Rosenquist K, Wennerberg J, Schildt EB, Bladstrom A, Hansson BG, Andersson G. Oral status, oral infections and some lifestyle factors as risk factors for oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden. Acta Otolaryngol (Stockh). 2005;125:1327-36.
7. Kreimer AR, Clifford GM, Boyle P, Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers. 2005;14:467-75.
8. D'Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM, Westra WH, Gillison ML. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med. 2007;356:1944-56.
9. Gillison ML, Shah KV. Role of mucosal human papillomavirus in nongenital cancers. J Natl Cancer Inst. 2003;9:57-65.
10. Lowe SW, Lin AW. Apoptosis in cancer. Carcinogenesis. 2000;21(3):485-95.
11. Van Themsche C, Leblanc V, Parent S, Asselin E. X-linked Inhibitor of apoptosis protein (XIAP) regulates PTEN ubiquitination, content, and compartmentalization. J Biol Chem. 2009;284:20462-6.
12. Salvesen GS, Duckett CS. IAP proteins: blocking the road to death's door. Nat Rev Mol Cell Biol. 2002;3:401-10.
13. Hunter AM, Lacasse EC, Korneluk RG. The inhibitors of apoptosis (IAPs) as cancer targets. Apoptosis. 2007;12:1543-68.
14. Heck JE, Berthiller J, Vaccarella S, Winn DM, Smith EM, Shan'gina O, Schwartz SM, Purdue MP, Pilarska A, Eluf-Neto J, Menezes A, McClean MD, Matos E, Koifman S, Kelsey KT, Herrero R, Hayes RB, Franceschi S, Wünsch-Filho V, Fernández L, Daudt AW, Curado MP, Chen C, Castellsagué X, Ferro G, Brennan P, Boffetta P, Hashibe M. Sexual behaviours and the risk of head and neck cancers: a pooled analysis in the international head and neck cancer epidemiology (INHANCE) consortium. Int J Epidemiol. 2010;39(1):166-81.
15. Fleskens S, Slootweg P. Grading systems in head and neck dysplasia: their prognostic value, weaknesses and utility. Head Neck Oncol. 2009;11(1):11.
16. Kennedy IM, Haddow JK, Clements JB. A negative regulatory element in the human papillomavirus type 16 genome acts at the level of late mRNA stability. J Virol. 1991;65(4):2093-7.
17. Hasegawa T, Suzuki K, Sakamoto C, Ohta K, Nishiki S, Hino M, Tatsumi N, Kitagawa S. Expression of the inhibitor of apoptosis (IAP) family members in human neutrophils: up-regulation of CIAP2 by granulocyte colony-stimulating factor and over expression of CIAP2 in chronic neutrophilic leukemia. Blood. 2003;101:1164-71.
18. Smith SD, Wheeler MA, Plescia J. Urine detection of survivin and diagnosis of bladder cancer. JAMA. 2001;285:324-8.
19. Meadus WJ. A semi-quantitative RT-PCR method to measure the in vivo effect of dietary conjugated linoleic acid on porcine muscle PPAR gene expression. Biol Proc Online. 2003;5:20-8.
20. Metz CE. Basic principles of ROC analysis. Semin Nucl Med. 1978;8(4):283-98.
21. Molinolo AA, Amornphimoltham P, Squarize CH, Castilho RM, Patel V, Gutkind JS. Dysregulated molecular networks in head and neck carcinogenesis. Oral Oncol. 2008;10:1016.
22. McKay SP, Gregoire L, Lonardo F, Reidy P, Mathog RH, Lancaster WD. Human papillomavirus (HPV) transcripts in malignant inverted papilloma are from integrated HPV DNA. Laryngoscope. 2005;115:1428-31.
23. Fakhry C, Westra WH, Li S, Cmelak A, Ridge JA, Pinto H, Forastiere A, Gillison ML. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. JNCI J Natl Cancer Inst. 2008;100(4):261-9.
24. Mehanna H, Jones TM, Gregoire V, Ang KK. Pharyngeal carcinoma related to human papillomavirus. BMJ. 2010;340:c1439.
25. Steinberg B, Norrild B. HPV oral, pharyngeal and laryngeal infections. APMIS. 2010;118:421.
26. Cao D, Begum S, Ali SZ, Westra WH. Expression of p16 in benign and malignant cystic squamous lesions of the neck. Hum Pathol. 2010;41(4):535-9.
27. Acha-Sagredo A, Ruesga MT, Aguirregaviria JI, Aguirre JM. HPV infection and oral carcinogenesis. Med Oral Patol Oral Cir Bucal. 2010;15(1):e1-2.
28. Kreimer AR, Randi G, Herrero R, Castellsague X, La Vecchia C, Franceschi S. Diet and body mass, and oral and oropharyngeal squamous cell carcinomas: analysis from the IARC multinational case-control study. Int J Cancer. 2006;118:2293-7.
29. Lindel K, Beer KT, Laissue J, Greiner RH, Aebersold DM. Human papillomavirus positive squamous cell carcinoma of the oropharynx: a radiosensitive subgroup of head and neck carcinoma. Cancer. 2001;92:805-13.
30. Gunnell AS, Tran TN, Torrång A, Dickman PW, Sparén P, Palmgren J, Ylitalo N. Synergy between cigarette smoking and human papillomavirus type 16 in cervical cancer in situ development. Cancer Epidemiol Biomarkers Prev. 2006;15(11):2141-7.
31. Bandala E, Espinosa M, Maldonado V, Melendez-Zajgla J. Inhibitor of apoptosis-1 (IAP-1) expression and apoptosis in non-small cell lung cancer cells exposed to gemcitabine. Biochem Pharmacol. 2001;62:13-9.
32. Herrero R, Castellsague X, Pawlita M, Lissowska J, Kee F, Balaram P, Rajkumar T, Sridhar H, Rose B, Pintos J. Human papillomavirus and oral cancer the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst. 2003;95:1772-83.